It is well known that a dysregulated low-grade systemic inflammatory milieu is present in T2DM, including C-reactive protein (CRP), tissue factor, interleukins (IL-1β, IL-6 and IL-8) and tumour necrosis factor alpha (TNF-α) [5–8]. Here, CRP is linked to type 2 diabetes mellitus.